Isolation and characterization of a novel bladder cancer cell line: Inhibition by epidermal growth factor

In Vitro Cellular and Developmental Biology - Animal

Volumn 34, Issue 9, 1998, Pages 722-728

  Pratsinis, Harris ^a   Saetta, Angelica ^a   Gagos, Sarantis ^a   Davaris, Panayiotis ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Gene mutations; Growth factors; Karyotype; Primary culture; Tumor markers

Indexed keywords

CYTOKERATIN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GROWTH FACTOR; TUMOR MARKER;

ARTICLE; BLADDER CANCER; CANCER CELL CULTURE; CELL ISOLATION; CELL STRUCTURE; CHROMOSOME ABERRATION; CODON; GENE MUTATION; HUMAN; HUMAN CELL; KARYOTYPE; ONCOGENE H RAS; ONCOGENE K RAS; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TRANSITIONAL CELL CARCINOMA;

EID: 0032418040     PISSN: 10712690     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11626-998-0068-z     Document Type: Article

References (20)

1. Berger, M. S.; Greenfield, C.; Gullick, W. J., et al. Evaluation of epidermal growth factor receptors in bladder tumours. Br. J. Cancer 56:533-537; 1987.
2. Browder, T. M.; Dunbar, C. E.; Nienhuis, A. W. Private and public autocrine loops in neoplastic cells. Cancer Cells 1:9-17; 1989.
3. Chen, P.-H.; Lin, S.-Y.; Wang, C.-K., et al. "Hot spots" mutation analysis of p53 gene in gastrointestinal cancers by amplification of naturally occurring and artificially created restriction sites. Clin. Chem. 39:2186-2191; 1993.
4. Czerniak, B.; Deitch, D.; Simmons, H., et al. Ha-ras gene codon 12 mutation and DNA ploidy in urinary bladder carcinoma. Br. J. Cancer 62:762-763; 1990.
5. Dangles, V.; Femenia, F.; Laine, V., et al. Two- and three-dimensional cell structures govern epidermal growth factor survival function in human bladder carcinoma cell lines. Cancer Res. 57:3360-3364; 1997.
6. Dubeau, L.; Jones, P. A. Growth of normal and neoplastic urothelium and response to epidermal growth factor in a defined serum-free medium. Cancer Res. 47:2107-2112; 1987.
7. Fujimoto, K.; Yamada, Y.; Okajima, E., et al. Frequent association of p53 gene mutation in invasive bladder cancer. Cancer Res. 52:1393-1398; 1992.
8. Gleave, M. E.; Hsieh, J.-T.; Wu, H.-C., et al. Epidermal growth factor receptor-mediated autocrine and paracrine stimulation of human transitional cell carcinoma. Cancer Res. 53:5300-5307; 1993.
9. Grimm, M.-O.; Jurgens, B.; Schulz, W. A., et al. Inactivation of tumor suppressor genes and deregulation of the c-myc gene in urothelial cancer cell lines. Urol. Res. 23:293-300; 1995.
10. Heim, S.; Mittelman, F. Cancer cytogenetics, 2nd ed. New York: Alan R. Liss; 1995:1-32; 358-368.
11. I.S.C.N. An international system for human cytogenetic nomenclature. Mitelman, F., ed. Basel: S. Karger; 1995.
12. Jakus, J.; Yeudall, W. A. Growth inhibitory concentrations of EGF induce p21 (WAF1/Cip1) and alter cell cycle control in squamous carcinoma cells. Oncogene 12:2369-2376; 1996.
13. King, E. D.; Matteson, J.; Jacobs, S. C., et al. Incidence of apoptosis, cell proliferation and bcl-2 expression in transitional cell carcinoma of the bladder association with tumor progression. J. Urol. 155:316-320; 1996.
14. Knowles, M. A.; Williamson, M. Mutation of H-ras is infrequent in bladder cancer: confirmation by single-strand conformation polymorphism analysis, designed restriction fragment length polymorphisms, and direct sequencing. Cancer Res. 53:133-139; 1993.
15. Li, Y.; White, R. Suppression of a human colon cancer cell line by introduction of an exogenous NF1 gene. Cancer Res. 56:2872-2876; 1996.
16. Sidransky, D.; Von Eschenbach, A.; Tsai, Y. C., et al. Identification of p53 gene mutations in bladder cancers and urine samples. Science 252:706-709; 1991.
17. Sporn, M. B.; Roberts, A. B. Autocrine secretion - 10 years later. Ann. Intern. Med. 117:408-114; 1992.
18. Taparowsky, E.; Suard, Y.; Fasano, O., et al. Activation of the T24 bladder carcinoma transforming gene is linked to a single amino acid change. Nature 300:762-765; 1982.
19. Turkus, M.; Powell, I.; Fakr, W. Cytogenetic studies of the bladder: prognostic implications. J. Urol. 148:44-46; 1992.
20. van der Bosch, J.; Ruller, S.; Horn, D., et al. Density-dependent tumor cell death and reversible cell cycle arrest: mutually exclusive models of monocyte-mediated growth control. Exp. Cell Res. 187:185-192; 1990.